31 results
8-K
EX-10.1
m8dbv nqgrhwc
4 Nov 22
Entry into a Material Definitive Agreement
5:00pm
DEFR14A
z0v7h
12 May 22
Revised proxy
5:00pm
8-K
EX-14.1
uqgdt2qs
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
qa3ht9y3dh4um7cici
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
0r43sh89hptvh1z
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
9mff6d8li4mb e2l
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-1.1
gw102i cw3xo
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am